BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 2273103)

  • 1. Toxic epidermal necrolysis (Lyell syndrome).
    Roujeau JC; Chosidow O; Saiag P; Guillaume JC
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1039-58. PubMed ID: 2273103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic epidermal necrolysis: a paradigm of critical illness.
    Estrella-Alonso A; Aramburu JA; González-Ruiz MY; Cachafeiro L; Sánchez MS; Lorente JA
    Rev Bras Ter Intensiva; 2017; 29(4):499-508. PubMed ID: 29340540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis in children: medical, surgical, and ophthalmologic considerations.
    Goyal S; Gupta P; Ryan CM; Kazlas M; Noviski N; Sheridan RL
    J Burn Care Res; 2009; 30(3):437-49. PubMed ID: 19349890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
    Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
    Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ofloxacin: a probable cause of toxic epidermal necrolysis.
    Melde SL
    Ann Pharmacother; 2001 Nov; 35(11):1388-90. PubMed ID: 11724089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic epidermal necrolysis in children--an update.
    Ringheanu M; Laude TA
    Clin Pediatr (Phila); 2000 Dec; 39(12):687-94. PubMed ID: 11156065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
    Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis after phenytoin usage in a brain trauma patient.
    Schummer W; Schummer C; Kuwert C
    J Neurosurg Anesthesiol; 2002 Jul; 14(3):229-33. PubMed ID: 12172297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients.
    Bastuji-Garin S; Zahedi M; Guillaume JC; Roujeau JC
    Age Ageing; 1993 Nov; 22(6):450-6. PubMed ID: 8310891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of toxic epidermal necrolysis in a pediatric burn center.
    Adzick NS; Kim SH; Bondoc CC; Quinby WC; Remensnyder JP
    Am J Dis Child; 1985 May; 139(5):499-502. PubMed ID: 3920898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Oliveira A; Sanches M; Selores M
    Acta Med Port; 2011 Dec; 24 Suppl 4():995-1002. PubMed ID: 22863510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Fritsch PO; Sidoroff A
    Am J Clin Dermatol; 2000; 1(6):349-60. PubMed ID: 11702611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
    N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with toxic epidermal necrolysis syndrome revisited.
    Ducic I; Shalom A; Rising W; Nagamoto K; Munster AM
    Plast Reconstr Surg; 2002 Sep; 110(3):768-73. PubMed ID: 12172137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.